Thus, the principle of this platform is defined by the anchoring of IFNβ-ACE2 to virion surfaces coupled with pinpoint targeting of antiviral activity to the site of infection by a mechanism impervious to differential fluid flow. This evidence concerns the gene IFNB1 and infection.